Industry Research Reports

Home > Reports > Service & Software > Global Contract Dose Manufacturing Market Research Report 2025

Global Contract Dose Manufacturing Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-21

Pages: 106 Pages

Report ld: 4140581

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Contract Dose Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

North American market for Contract Dose Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Contract Dose Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Contract Dose Manufacturing in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Contract Dose Manufacturing include Lonza, Catalent, Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics Contract Services, AMRI, Famar, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Contract Dose Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Dose Manufacturing.

The Contract Dose Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contract Dose Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Contract Dose Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Lonza
Catalent
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics Contract Services
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup(Eurofins)
Thermo Fisher Scientific
Piramal Pharma Solutions
AbbVie Contract Manufacturing
Baxter BioPharma Solutions
Fareva
NextPharma
Emergent BioSolution

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

API Development
Manufacturing
Drug Delivery
Others

Segment by Application

Pharmaceutical Company
Biotechnology Company
Generic Company
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contract Dose Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Contract Dose Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 API Development

1.2.3 Manufacturing

1.2.4 Drug Delivery

1.2.5 Others

1.3 Market by Application

1.3.1 Global Contract Dose Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Generic Company

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Contract Dose Manufacturing Market Perspective (2020-2031)

2.2 Global Contract Dose Manufacturing Growth Trends by Region

2.2.1 Global Contract Dose Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Contract Dose Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Contract Dose Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Contract Dose Manufacturing Market Dynamics

2.3.1 Contract Dose Manufacturing Industry Trends

2.3.2 Contract Dose Manufacturing Market Drivers

2.3.3 Contract Dose Manufacturing Market Challenges

2.3.4 Contract Dose Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Contract Dose Manufacturing Players by Revenue

3.1.1 Global Top Contract Dose Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Contract Dose Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Contract Dose Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Contract Dose Manufacturing Revenue

3.4 Global Contract Dose Manufacturing Market Concentration Ratio

3.4.1 Global Contract Dose Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Contract Dose Manufacturing Revenue in 2024

3.5 Global Key Players of Contract Dose Manufacturing Head office and Area Served

3.6 Global Key Players of Contract Dose Manufacturing, Product and Application

3.7 Global Key Players of Contract Dose Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Contract Dose Manufacturing Breakdown Data by Type

4.1 Global Contract Dose Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Contract Dose Manufacturing Forecasted Market Size by Type (2026-2031)

5 Contract Dose Manufacturing Breakdown Data by Application

5.1 Global Contract Dose Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Contract Dose Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Contract Dose Manufacturing Market Size (2020-2031)

6.2 North America Contract Dose Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Contract Dose Manufacturing Market Size by Country (2020-2025)

6.4 North America Contract Dose Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Contract Dose Manufacturing Market Size (2020-2031)

7.2 Europe Contract Dose Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Contract Dose Manufacturing Market Size by Country (2020-2025)

7.4 Europe Contract Dose Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Contract Dose Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Contract Dose Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Contract Dose Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Contract Dose Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Contract Dose Manufacturing Market Size (2020-2031)

9.2 Latin America Contract Dose Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Contract Dose Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Contract Dose Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Contract Dose Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Contract Dose Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Contract Dose Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Contract Dose Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Contract Dose Manufacturing Introduction

11.1.4 Lonza Revenue in Contract Dose Manufacturing Business (2020-2025)

11.1.5 Lonza Recent Development

11.2 Catalent

11.2.1 Catalent Company Details

11.2.2 Catalent Business Overview

11.2.3 Catalent Contract Dose Manufacturing Introduction

11.2.4 Catalent Revenue in Contract Dose Manufacturing Business (2020-2025)

11.2.5 Catalent Recent Development

11.3 Aenova

11.3.1 Aenova Company Details

11.3.2 Aenova Business Overview

11.3.3 Aenova Contract Dose Manufacturing Introduction

11.3.4 Aenova Revenue in Contract Dose Manufacturing Business (2020-2025)

11.3.5 Aenova Recent Development

11.4 Siegfried

11.4.1 Siegfried Company Details

11.4.2 Siegfried Business Overview

11.4.3 Siegfried Contract Dose Manufacturing Introduction

11.4.4 Siegfried Revenue in Contract Dose Manufacturing Business (2020-2025)

11.4.5 Siegfried Recent Development

11.5 Recipharm

11.5.1 Recipharm Company Details

11.5.2 Recipharm Business Overview

11.5.3 Recipharm Contract Dose Manufacturing Introduction

11.5.4 Recipharm Revenue in Contract Dose Manufacturing Business (2020-2025)

11.5.5 Recipharm Recent Development

11.6 Strides Shasun

11.6.1 Strides Shasun Company Details

11.6.2 Strides Shasun Business Overview

11.6.3 Strides Shasun Contract Dose Manufacturing Introduction

11.6.4 Strides Shasun Revenue in Contract Dose Manufacturing Business (2020-2025)

11.6.5 Strides Shasun Recent Development

11.7 Piramal

11.7.1 Piramal Company Details

11.7.2 Piramal Business Overview

11.7.3 Piramal Contract Dose Manufacturing Introduction

11.7.4 Piramal Revenue in Contract Dose Manufacturing Business (2020-2025)

11.7.5 Piramal Recent Development

11.8 Metrics Contract Services

11.8.1 Metrics Contract Services Company Details

11.8.2 Metrics Contract Services Business Overview

11.8.3 Metrics Contract Services Contract Dose Manufacturing Introduction

11.8.4 Metrics Contract Services Revenue in Contract Dose Manufacturing Business (2020-2025)

11.8.5 Metrics Contract Services Recent Development

11.9 AMRI

11.9.1 AMRI Company Details

11.9.2 AMRI Business Overview

11.9.3 AMRI Contract Dose Manufacturing Introduction

11.9.4 AMRI Revenue in Contract Dose Manufacturing Business (2020-2025)

11.9.5 AMRI Recent Development

11.10 Famar

11.10.1 Famar Company Details

11.10.2 Famar Business Overview

11.10.3 Famar Contract Dose Manufacturing Introduction

11.10.4 Famar Revenue in Contract Dose Manufacturing Business (2020-2025)

11.10.5 Famar Recent Development

11.11 WuXi AppTech

11.11.1 WuXi AppTech Company Details

11.11.2 WuXi AppTech Business Overview

11.11.3 WuXi AppTech Contract Dose Manufacturing Introduction

11.11.4 WuXi AppTech Revenue in Contract Dose Manufacturing Business (2020-2025)

11.11.5 WuXi AppTech Recent Development

11.12 Asymchem

11.12.1 Asymchem Company Details

11.12.2 Asymchem Business Overview

11.12.3 Asymchem Contract Dose Manufacturing Introduction

11.12.4 Asymchem Revenue in Contract Dose Manufacturing Business (2020-2025)

11.12.5 Asymchem Recent Development

11.13 Porton

11.13.1 Porton Company Details

11.13.2 Porton Business Overview

11.13.3 Porton Contract Dose Manufacturing Introduction

11.13.4 Porton Revenue in Contract Dose Manufacturing Business (2020-2025)

11.13.5 Porton Recent Development

11.14 Amatsigroup(Eurofins)

11.14.1 Amatsigroup(Eurofins) Company Details

11.14.2 Amatsigroup(Eurofins) Business Overview

11.14.3 Amatsigroup(Eurofins) Contract Dose Manufacturing Introduction

11.14.4 Amatsigroup(Eurofins) Revenue in Contract Dose Manufacturing Business (2020-2025)

11.14.5 Amatsigroup(Eurofins) Recent Development

11.15 Thermo Fisher Scientific

11.15.1 Thermo Fisher Scientific Company Details

11.15.2 Thermo Fisher Scientific Business Overview

11.15.3 Thermo Fisher Scientific Contract Dose Manufacturing Introduction

11.15.4 Thermo Fisher Scientific Revenue in Contract Dose Manufacturing Business (2020-2025)

11.15.5 Thermo Fisher Scientific Recent Development

11.16 Piramal Pharma Solutions

11.16.1 Piramal Pharma Solutions Company Details

11.16.2 Piramal Pharma Solutions Business Overview

11.16.3 Piramal Pharma Solutions Contract Dose Manufacturing Introduction

11.16.4 Piramal Pharma Solutions Revenue in Contract Dose Manufacturing Business (2020-2025)

11.16.5 Piramal Pharma Solutions Recent Development

11.17 AbbVie Contract Manufacturing

11.17.1 AbbVie Contract Manufacturing Company Details

11.17.2 AbbVie Contract Manufacturing Business Overview

11.17.3 AbbVie Contract Manufacturing Contract Dose Manufacturing Introduction

11.17.4 AbbVie Contract Manufacturing Revenue in Contract Dose Manufacturing Business (2020-2025)

11.17.5 AbbVie Contract Manufacturing Recent Development

11.18 Baxter BioPharma Solutions

11.18.1 Baxter BioPharma Solutions Company Details

11.18.2 Baxter BioPharma Solutions Business Overview

11.18.3 Baxter BioPharma Solutions Contract Dose Manufacturing Introduction

11.18.4 Baxter BioPharma Solutions Revenue in Contract Dose Manufacturing Business (2020-2025)

11.18.5 Baxter BioPharma Solutions Recent Development

11.19 Fareva

11.19.1 Fareva Company Details

11.19.2 Fareva Business Overview

11.19.3 Fareva Contract Dose Manufacturing Introduction

11.19.4 Fareva Revenue in Contract Dose Manufacturing Business (2020-2025)

11.19.5 Fareva Recent Development

11.20 NextPharma

11.20.1 NextPharma Company Details

11.20.2 NextPharma Business Overview

11.20.3 NextPharma Contract Dose Manufacturing Introduction

11.20.4 NextPharma Revenue in Contract Dose Manufacturing Business (2020-2025)

11.20.5 NextPharma Recent Development

11.21 Emergent BioSolution

11.21.1 Emergent BioSolution Company Details

11.21.2 Emergent BioSolution Business Overview

11.21.3 Emergent BioSolution Contract Dose Manufacturing Introduction

11.21.4 Emergent BioSolution Revenue in Contract Dose Manufacturing Business (2020-2025)

11.21.5 Emergent BioSolution Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Contract Dose Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of API Development

Table 3. Key Players of Manufacturing

Table 4. Key Players of Drug Delivery

Table 5. Key Players of Others

Table 6. Global Contract Dose Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Contract Dose Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Contract Dose Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Contract Dose Manufacturing Market Share by Region (2020-2025)

Table 10. Global Contract Dose Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Contract Dose Manufacturing Market Share by Region (2026-2031)

Table 12. Contract Dose Manufacturing Market Trends

Table 13. Contract Dose Manufacturing Market Drivers

Table 14. Contract Dose Manufacturing Market Challenges

Table 15. Contract Dose Manufacturing Market Restraints

Table 16. Global Contract Dose Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Contract Dose Manufacturing Market Share by Players (2020-2025)

Table 18. Global Top Contract Dose Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Dose Manufacturing as of 2024)

Table 19. Ranking of Global Top Contract Dose Manufacturing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Contract Dose Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Contract Dose Manufacturing, Headquarters and Area Served

Table 22. Global Key Players of Contract Dose Manufacturing, Product and Application

Table 23. Global Key Players of Contract Dose Manufacturing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Contract Dose Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Contract Dose Manufacturing Revenue Market Share by Type (2020-2025)

Table 27. Global Contract Dose Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Contract Dose Manufacturing Revenue Market Share by Type (2026-2031)

Table 29. Global Contract Dose Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Contract Dose Manufacturing Revenue Market Share by Application (2020-2025)

Table 31. Global Contract Dose Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Contract Dose Manufacturing Revenue Market Share by Application (2026-2031)

Table 33. North America Contract Dose Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Contract Dose Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Contract Dose Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Contract Dose Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Contract Dose Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Contract Dose Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Contract Dose Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Contract Dose Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Contract Dose Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Contract Dose Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Contract Dose Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Contract Dose Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Contract Dose Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Contract Dose Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Contract Dose Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Lonza Company Details

Table 49. Lonza Business Overview

Table 50. Lonza Contract Dose Manufacturing Product

Table 51. Lonza Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 52. Lonza Recent Development

Table 53. Catalent Company Details

Table 54. Catalent Business Overview

Table 55. Catalent Contract Dose Manufacturing Product

Table 56. Catalent Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 57. Catalent Recent Development

Table 58. Aenova Company Details

Table 59. Aenova Business Overview

Table 60. Aenova Contract Dose Manufacturing Product

Table 61. Aenova Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 62. Aenova Recent Development

Table 63. Siegfried Company Details

Table 64. Siegfried Business Overview

Table 65. Siegfried Contract Dose Manufacturing Product

Table 66. Siegfried Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 67. Siegfried Recent Development

Table 68. Recipharm Company Details

Table 69. Recipharm Business Overview

Table 70. Recipharm Contract Dose Manufacturing Product

Table 71. Recipharm Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 72. Recipharm Recent Development

Table 73. Strides Shasun Company Details

Table 74. Strides Shasun Business Overview

Table 75. Strides Shasun Contract Dose Manufacturing Product

Table 76. Strides Shasun Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 77. Strides Shasun Recent Development

Table 78. Piramal Company Details

Table 79. Piramal Business Overview

Table 80. Piramal Contract Dose Manufacturing Product

Table 81. Piramal Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 82. Piramal Recent Development

Table 83. Metrics Contract Services Company Details

Table 84. Metrics Contract Services Business Overview

Table 85. Metrics Contract Services Contract Dose Manufacturing Product

Table 86. Metrics Contract Services Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 87. Metrics Contract Services Recent Development

Table 88. AMRI Company Details

Table 89. AMRI Business Overview

Table 90. AMRI Contract Dose Manufacturing Product

Table 91. AMRI Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 92. AMRI Recent Development

Table 93. Famar Company Details

Table 94. Famar Business Overview

Table 95. Famar Contract Dose Manufacturing Product

Table 96. Famar Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 97. Famar Recent Development

Table 98. WuXi AppTech Company Details

Table 99. WuXi AppTech Business Overview

Table 100. WuXi AppTech Contract Dose Manufacturing Product

Table 101. WuXi AppTech Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 102. WuXi AppTech Recent Development

Table 103. Asymchem Company Details

Table 104. Asymchem Business Overview

Table 105. Asymchem Contract Dose Manufacturing Product

Table 106. Asymchem Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 107. Asymchem Recent Development

Table 108. Porton Company Details

Table 109. Porton Business Overview

Table 110. Porton Contract Dose Manufacturing Product

Table 111. Porton Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 112. Porton Recent Development

Table 113. Amatsigroup(Eurofins) Company Details

Table 114. Amatsigroup(Eurofins) Business Overview

Table 115. Amatsigroup(Eurofins) Contract Dose Manufacturing Product

Table 116. Amatsigroup(Eurofins) Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 117. Amatsigroup(Eurofins) Recent Development

Table 118. Thermo Fisher Scientific Company Details

Table 119. Thermo Fisher Scientific Business Overview

Table 120. Thermo Fisher Scientific Contract Dose Manufacturing Product

Table 121. Thermo Fisher Scientific Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 122. Thermo Fisher Scientific Recent Development

Table 123. Piramal Pharma Solutions Company Details

Table 124. Piramal Pharma Solutions Business Overview

Table 125. Piramal Pharma Solutions Contract Dose Manufacturing Product

Table 126. Piramal Pharma Solutions Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 127. Piramal Pharma Solutions Recent Development

Table 128. AbbVie Contract Manufacturing Company Details

Table 129. AbbVie Contract Manufacturing Business Overview

Table 130. AbbVie Contract Manufacturing Contract Dose Manufacturing Product

Table 131. AbbVie Contract Manufacturing Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 132. AbbVie Contract Manufacturing Recent Development

Table 133. Baxter BioPharma Solutions Company Details

Table 134. Baxter BioPharma Solutions Business Overview

Table 135. Baxter BioPharma Solutions Contract Dose Manufacturing Product

Table 136. Baxter BioPharma Solutions Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 137. Baxter BioPharma Solutions Recent Development

Table 138. Fareva Company Details

Table 139. Fareva Business Overview

Table 140. Fareva Contract Dose Manufacturing Product

Table 141. Fareva Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 142. Fareva Recent Development

Table 143. NextPharma Company Details

Table 144. NextPharma Business Overview

Table 145. NextPharma Contract Dose Manufacturing Product

Table 146. NextPharma Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 147. NextPharma Recent Development

Table 148. Emergent BioSolution Company Details

Table 149. Emergent BioSolution Business Overview

Table 150. Emergent BioSolution Contract Dose Manufacturing Product

Table 151. Emergent BioSolution Revenue in Contract Dose Manufacturing Business (2020-2025) & (US$ Million)

Table 152. Emergent BioSolution Recent Development

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Contract Dose Manufacturing Picture

Figure 2. Global Contract Dose Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Contract Dose Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. API Development Features

Figure 5. Manufacturing Features

Figure 6. Drug Delivery Features

Figure 7. Others Features

Figure 8. Global Contract Dose Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Contract Dose Manufacturing Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Company Case Studies

Figure 11. Biotechnology Company Case Studies

Figure 12. Generic Company Case Studies

Figure 13. Others Case Studies

Figure 14. Contract Dose Manufacturing Report Years Considered

Figure 15. Global Contract Dose Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Contract Dose Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Contract Dose Manufacturing Market Share by Region: 2024 VS 2031

Figure 18. Global Contract Dose Manufacturing Market Share by Players in 2024

Figure 19. Global Top Contract Dose Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Dose Manufacturing as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Contract Dose Manufacturing Revenue in 2024

Figure 21. North America Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Contract Dose Manufacturing Market Share by Country (2020-2031)

Figure 23. United States Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Contract Dose Manufacturing Market Share by Country (2020-2031)

Figure 27. Germany Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Contract Dose Manufacturing Market Share by Region (2020-2031)

Figure 35. China Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Contract Dose Manufacturing Market Share by Country (2020-2031)

Figure 43. Mexico Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Contract Dose Manufacturing Market Share by Country (2020-2031)

Figure 47. Turkey Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Contract Dose Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Lonza Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 51. Catalent Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 52. Aenova Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 53. Siegfried Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 54. Recipharm Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 55. Strides Shasun Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 56. Piramal Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 57. Metrics Contract Services Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 58. AMRI Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 59. Famar Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 60. WuXi AppTech Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 61. Asymchem Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 62. Porton Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 63. Amatsigroup(Eurofins) Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 65. Piramal Pharma Solutions Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 66. AbbVie Contract Manufacturing Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 67. Baxter BioPharma Solutions Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 68. Fareva Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 69. NextPharma Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 70. Emergent BioSolution Revenue Growth Rate in Contract Dose Manufacturing Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Contract Dose Manufacturing market? zhanKai

The top companies in the global Contract Dose Manufacturing market are Lonza、Catalent、Aenova.

Related Reports

Contract Dose Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Contract Dose Manufacturing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 145
USD 3950.00
(Single User License)
Global Contract Dose Manufacturing Market Research Report 2026
The global Contract Dose Manufacturing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 143
USD 2900.00
(Single User License)
Global Contract Dose Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Contract Dose Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 173
USD 4900.00
(Single User License)
Global Contract Dose Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Contract Dose Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 116
USD 4250.00
(Single User License)
Contract Dose Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Contract Dose Manufacturing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 152
USD 3950.00
(Single User License)
Global Contract Dose Manufacturing Market Insights, Forecast to 2030
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Published Date: 2024-04-06
Pages: 129
USD 4900.00
(Single User License)
Global Contract Dose Manufacturing Market Research Report 2024
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Published Date: 2024-01-11
Pages: 105
USD 2900.00
(Single User License)

Contract Dose Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Contract Dose Manufacturing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 145
USD 3950.00 (Single User License)
Global Contract Dose Manufacturing Market Research Report 2026
The global Contract Dose Manufacturing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 143
USD 2900.00 (Single User License)
Global Contract Dose Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Contract Dose Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 173
USD 4900.00 (Single User License)
Global Contract Dose Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Contract Dose Manufacturing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 116
USD 4250.00 (Single User License)
Contract Dose Manufacturing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Contract Dose Manufacturing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 152
USD 3950.00 (Single User License)
Global Contract Dose Manufacturing Market Insights, Forecast to 2030
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Published: 2024-04-06
Pages: 129
USD 4900.00 (Single User License)
Global Contract Dose Manufacturing Market Research Report 2024
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Published: 2024-01-11
Pages: 105
USD 2900.00 (Single User License)